# 25iP-NBOMe
*Source: https://en.wikipedia.org/wiki/25iP-NBOMe*

25iP-NBOMe, also known as 2C-iP-NBOMe or NBOMe-2C-iP, is a derivative of the phenethylamine hallucinogen 2C-iP, which has been encountered as a novel designer drug.

## Toxicity and harm potential

### Neurotoxic and cardiotoxic actions

### Emergency treatment

## Interactions

## Pharmacology

The interactions of 25iP-NBOMe with the Î¼-opioid receptor have been described.

## History

25iP-NBOMe was first described in the scientific literature by at least 2014, when it was encountered as a novel designer drug.

## Society and culture

### Legal status

#### United Kingdom

This substance is a Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.
